OK

Omar Kayaleh

Physician · Orlando Health

Credentials: · · · · ·

History

Orlando Health
Present

Hematology and Medical Oncology
1988–1991
Internal Medicine
1985–1988
University of Florida College of Medicine
1981–1985

Research

Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck…
The Lancet Oncology · 2015 · 224 citations
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
British Journal of Cancer · 2014 · 94 citations
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma
Investigational New Drugs · 2012 · 44 citations

Anita Turk
2 papers
Brian Ramnaraign
2 papers
Ibrahim Nassour
2 papers
IS
Ilyas Sahin
2 papers
Jesus Fabregas
2 papers
KR
Karen Russell
2 papers
Kate Hitchcock
2 papers
Ryan Thomas
2 papers
Sherise Rogers
2 papers
Steven Hughes
2 papers
Thomas George
2 papers
AS
Abby Siegel
1 paper